|
D10.Concomitant products: gia80mtc, cartridge gia80mtc medthk tristp (lot n5j1414uy).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
It was reported that during a procedure, while the technician was assembling the device, it was observed that the area where the reload mechanism was inserted was broken.The device was not then used.To resolve the issue, a new stapler was used.
|
|
Additional information: d9, g3, h3, h6 h3 evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted the firing knob of the instrument was not fully retracted.Functionally, the instrument firing knob was fully retracted.The sulu was loaded into the returned instrument.The sulu unloaded and loaded repeatedly without difficulty.The sulu and instrument were applied to test media with acceptable results.The firing knob advanced and retracted without difficulty.The knife cut completely and cleanly.The remaining staples deployed and formed properly.It was reported that the jaws of the device was damaged.The reported issue could not be confirmed.The most likely cause could not be established from the information available.The evaluation detected an unreported condition: damaged interlock and incomplete stroke that are unrelated to the reported condition.Visual examination of the staple cartridge noted that the loading unit was partially applied and the interlock was engaged, and damaged.The sulu was dipped.Functionally, the broken interlock was removed to perform functional testing.The product analysis noted evidence that the device was not used as intended.The damaged lockout may occur when after firing the unit the lockout engages, if the unit was unclamped and then clamped again the lockout gets caught and causes the observed damage.The incomplete stroke condition may occur if the firing stroke is not complete and the firing knob is not fully retracted after firing or if the instrument is applied against an excessive amount of tissue during the clinical application.If the firing knob is not fully retracted, difficulty in unloading the loading unit may be experienced, and may prevent further loading from occurring.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.The instructions included with this device provide the following guidance: when a fired instrument is opened, the lockout device will deploy.The safety lock out prevents clamping of the instrument with a cartridge that has been fired.The instrument should not be used on tissue such as liver or spleen where compressibility is such that closure of the instrument would be destructive.Tissue thickness should be carefully evaluated before firing any stapler.If the tissue can not comfortably compress to the specified minimum requirement, or compresses to less than this requirement, the tissue may be too thick or too thin for the selected staple size.Do not rotate the firing knob during firing.Rotating the knob during firing may cause damage and possible instrument malfunction.The appropriate tissue ranges for safe use and instructions for proper use of stapler were also stated.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|